Drug Type Synthetic peptide |
Synonyms- |
Target |
Mechanism ANXA1 agonists(annexin A1 agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Inflammation | Preclinical | SG | 08 Feb 2023 | |
Thrombosis | Preclinical | SG | 08 Feb 2023 |